Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Procyon Biopharma Inc. -- Ignore unavailable to you. Want to Upgrade?

To: William Whitehead Jr. who wrote (72)	11/13/1998 10:27:00 PM
From: thebeach	Read Replies (1) \| Respond to of 356

Not a problem Whitey,I was there and everything is going very well. After attending the meeting I walked away more satisfied than ever. Phase one clinical trials are scheduled to begin sometime in 1999 for the PSP-94 for prostate cancer and also for the ANA technology. Talks with marketing partners are also planned for the 2 near term products,the Fibrostat and the Colopath. I talked with 2 gentlemen from the marketing firm Procyon hired (Linear Capital) and they have started to plan meetings with analysts in Toronto and Montreal. When I quizzed these guys on how Procyon has been received so far,they responded that Procyon impressed them with their business plan. Things could not be in better shape for us. Please call the company to get further explanations if necessary.Thanks and bye for now.